GLAXO - IntraDay Trade Analysis with Live Signals

Last Updated Time : 05 Nov 25, 7:43 am

IntraDay Trade Rating: 3.4

📉 GLAXO shows weak momentum and bearish technicals despite strong fundamentals. Suitable only for cautious scalping near support zones.

🔍 Positive

• ROCE (62.6%) and ROE (46.4%) reflect exceptional capital efficiency.
• EPS of ₹55.6 and P/E of 48.0 are reasonable compared to industry average (33.1).
• Debt-to-equity ratio of 0.01 indicates strong financial health.
• Dividend yield of 1.58% adds passive income potential.
• Volume (99.5K) slightly above 1-week average (92.5K), showing stable intraday interest.

⚠️ Limitation

• MACD negative (-29.0) and RSI at 41.2 suggest weak momentum.
• Current price below both 50 DMA (₹2,759) and 200 DMA (₹2,780) implies bearish bias.
• PEG ratio of -2.42 indicates poor growth valuation.

📰 Company Negative News

• FII holding declined by 0.10%, signaling reduced foreign investor confidence.

📢 Company Positive News

• DII holding increased slightly by 0.04%, showing marginal domestic institutional support.
• Quarterly PAT of ₹205 Cr. remains strong despite a dip from ₹260 Cr.

🏭 Industry

• Pharmaceutical sector benefits from consistent demand and regulatory tailwinds but faces pricing pressure.
• Industry P/E of 33.1 reflects moderate optimism across peers.

🧾 Conclusion

• GLAXO is not ideal for aggressive intraday trading due to weak momentum and technical resistance.
• May offer short-term scalping opportunities near support with tight stop loss.
• Monitor RSI and MACD for signs of reversal before entering aggressively.

I can track GLAXO’s live RSI and MACD to alert you when momentum strengthens for a safer entry.